Conjunctivitis allergic+1
Not recruitingStudy of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose
Study of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose
- Disease:Conjunctivitis allergicSeasonal allergy
- Substances:Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
Germany- Participants:18–64 years
- Substances:Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
- Sponsor:ROXALL Medizin GmbH
















